Meticulous Research® – leading global market research company is researching on Single-use Bioreactors Market titled- “Single-use Bioreactors Market by Product (Single-use Bioreactor, Media Bags), Usage (Lab-scale, Large-scale), Type (Stirred tank, Bubble-Column), cell type (Mammalian, bacteria), application (Bioproduction, Research), End user (Pharma & biotech, CROs)- Global Forecast to 2025″.
Increase in Government Support for Biopharmaceutical Research Offers New Growth Avenues for Single-use Bioreactors Market
Governments in developed as well as developing nations are offering funding for propagation of biotechnology and biopharmaceutical research. For instance, in India, in 2017, Department of Biotechnology (DBT) and World Bank initiated a program – Innovate in India (I3) – to facilitate research related to the discovery of biopharmaceuticals. Similarly, in the U.S., National Institute of Health (NIH) collaborated with 11 biopharmaceutical companies to launch the “Partnership for Accelerating Cancer Therapies (PACT)”, a five-year public-private research collaboration. The aim of the collaboration is to develop immunotherapy for cancers with total investment of $215 million. Furthermore, in Korea, the government announced second Basic Development Plan for Bioengineering (2012). According to which, the Korean government increased biotech investments to KRW 9.7 trillion ($8.35 billion) through 2016. In addition, Korean government announced the “Government-Wide Mid- to Long-Term Action Plans to Promote R&D for National Healthcare” in 2013 – to promote growth of biotechnology and healthcare industry.
Accessible Exclusive Sample Copy of this Report @
Single-Use Bioreactor Systems Segment Dominated the Single-Use Bioreactors Market in 2018
Single-use bioreactor system commanded the largest share of the single-use bioreactors market in 2018 due to its better flexibility, no sterilization demand, and low operational cost without compromising the quality of the drug produced. This addresses the complexities associated with multi drug manufacturing processes while providing maximum savings on the time spent to prepare the bioreactor for the next batch.
Mammalian Cells to Witness the Largest Demand Through 2025
Mammalian cells commanded the largest share of single-use bioreactor market in 2018. This is mainly attributed to proper protein folding, post-translational modifications, and product assembly, which plays an important role to initiate complete biological activity in humans.
Asia-Pacific: The Fastest Growing Regional Market
North America commanded the largest share of the global single-use bioreactors market in 2018, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific is the fastest growing regional market due to accelerated economic growth of many countries in this region and growing government focus on pharmaceutical research. In addition, government initiatives to escalate the drug development process, rising public & private funding for R&D, and rising contract research and manufacturing activities – are the key factors propelling the growth of the Asia-Pacific single-use bioreactors market.
Download free sample report and gain crucial industry insights @
Key players in the Single-use Bioreactors Market
In the single-use bioreactors market, the leading players are consistently developing new products with improved performance, higher efficiency, and low operational costs. In March 2018, Sartorius Stedim Biotech launched ambr 250 high throughput (ht) perfusion system for rapid cell culture perfusion process development for production of therapeutic antibodies. Similarly, in April 2016, Merck Millipore launched Mobius 1000-liter single-use bioreactor, which has greater flexibility and continuity for scale-up. Furthermore, in November 2016, Finesse Solutions, Inc. (U.S.), launched SmartVessel, a single-use 3-liter bioreactor vessel.
The key players operating in the global single-use bioreactors market are GE Healthcare, Merck Group, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, Applikon Biotechnology B.V., Solaris Biotechnology SRL, Cellexus Ltd, CESCO Bioengineering Co., Ltd., PBS Biotech, Inc., Pierre Guerin Technologies, Distek, Inc., Parker-Hannifin Corporation, Celltainer Biotech B.V., and Infors AG.
Enquire Before Buying:
Contact Sales- +91-744-7780008